对于连接体对抗的不寻常机制
概括
对免疫球蛋白E (IgE) 受体的联结亲和性影响细胞信号传递. 弱结合的连接体可以阻断信号级联,而高亲缘关系的连接体可以促进它们,这种机制可能适用于T细胞激活.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞信号传输 细胞信号传输
- 生物化学 生物化学
背景情况:
- 通过免疫球蛋白E (IgE) 受体激活母细胞是过敏反应中的一个关键过程.
- 结合IgE受体的配体的亲和力可以调节下游的信号通路.
- 了解这些机制对于开发有针对性的疗法至关重要.
研究的目的:
- 为了研究联结体亲和力和IgE受体介导的迟到早期信号事件的比率之间的关系.
- 阐明基于连接体亲缘关系的差异信号结果背后的分子机制.
- 探索这些发现对T细胞激活的潜在适用性.
主要方法:
- 利用对IgE受体的不同联结体 afinities来刺激巨细胞.
- 量化和比较早期和晚期信号事件的动力学.
- 分析了启动激酶在信号传播中的作用.
主要成果:
- 观察到连接器亲和力与迟到早期信号事件的比率之间存在相关性.
- 弱结合的连接体导致受体聚类,隔离启动激酶,阻碍下游信号传输.
- 由于有效的激酶招募,高亲和度联体促进了信号级联.
结论:
- 连接体亲和力极大地决定了IgE受体介导的信号传递的程度和性质.
- 受体聚类动力学受到连接体亲和力的影响,在控制信号传导方面发挥着关键作用.
- 鉴定出来的机制可能有助于了解某些体对T细胞的对抗作用.
相关概念视频
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...


